HS860 Unit 1 Lymphedema Surveillance Concept Paper Example

From a Worry About Swollen Arms to an Answerable Question: A Unit 1 Concept Paper on Lymphedema Surveillance After Breast Cancer Surgery

[Student Name]

Purdue University Global

HS860: Doctoral Project I: Project Proposal

Unit 1 Concept Paper

[Instructor Name]

[Date]

The cancer center, the candidate and all local figures are composite and shown as placeholders; no data have been collected, and the published studies cited are real.

The Practice Problem

Breast cancer-related lymphedema is a chronic swelling of the arm that can follow surgery or radiation to the lymph nodes in the armpit. It is common. A meta-analysis of 72 studies estimated that about one woman in five develops arm lymphedema after breast cancer, with incidence roughly four times higher after axillary lymph node dissection than after sentinel node biopsy and with new cases still appearing well into the second year (DiSipio et al., 2013). Once established, lymphedema is managed rather than cured, through compression, manual drainage and exercise, often for life.

Detection can come early, before swelling is visible. In a cohort followed from a preoperative baseline, women whose arm volume rose by a small amount were treated with a short course of compression garments, and the subclinical swelling resolved and stayed resolved months later (Stout Gergich et al., 2008). That finding underpins the prospective surveillance model, which recommends a baseline measurement before cancer treatment and scheduled measurements afterward, so that rehabilitation can intervene early (Stout et al., 2012).

At the candidate's center, the model exists on paper. The breast program adopted a surveillance pathway [three] years ago: baseline measurement at the preoperative visit, then measurements at 3, 6, 12 and 24 months. In the last year, [22] percent of women who had axillary dissection had a baseline measurement and [31] percent attended a first surveillance visit within four months. Most women referred to the lymphedema clinic arrive with visible swelling.

What the Clinic Sees

The clinic's own caseload shows the consequence of the gap. In the last year, [46] women with breast cancer-related lymphedema began treatment there. The candidate's review of the clinic's intake log, an internal quality record rather than research data, suggests that most arrived after a family member, a primary care clinician or the women themselves noticed a difference in sleeve fit or ring size, not through a surveillance visit. Several had been referred at discharge, but their first appointment had been canceled or never scheduled. A few told intake staff they had not known that swelling could be caught early. These impressions are not evidence for the project, which has not begun, but they explain why the candidate suspects the pathway fails at more than one step.

Who Has a Stake

Four groups have a stake in the answer. Women at high risk have the most to gain from early detection. Surgeons and nurse navigators control the preoperative visit and discharge, where the baseline and referral happen. Rehabilitation staff control the surveillance visits. Program leaders must decide where to invest effort. Each group is likely to locate the failure somewhere other than its own step, which is a further reason to examine every step with the same method.

Why It Matters

Late detection means more intensive treatment, longer clinic courses, higher costs and more lasting effects on arm function and quality of life. Women who miss the baseline cannot later be measured against their own starting point, so small changes go unseen. For the center, an unused pathway also means the program is not delivering a standard of care professional bodies recommend.

What Is Not Known

The literature establishes that surveillance can detect lymphedema early and that early treatment works. It says much less about why surveillance pathways that exist on paper are not followed in community settings. Most published surveillance programs come from academic centers with dedicated research staff. Little is known about where, in a community center's ordinary flow from diagnosis to surgery to follow-up, women leave the path.

The evidence answers whether surveillance works; it does not answer why a community center that adopted it measures only one woman in five before surgery.

The Question, Narrowed

The candidate's first idea was to increase surveillance and reduce lymphedema at the center. That is an improvement project, not a doctoral study, and it promises outcomes one candidate cannot deliver in a year. Narrowed, the concept becomes descriptive: For a two-year cohort of the center's patients treated with node dissection, at which steps of the surveillance pathway, preoperative measurement, referral at discharge and first surveillance visit, do women leave the path, and how do patients and staff explain those departures?

What the Project Leaves Alone

The project does not test an intervention or measure lymphedema incidence. It does not compare measurement methods such as tape measurement and bioimpedance spectroscopy, although a trial has compared them (Ridner et al., 2019). It does not include women who had sentinel node biopsy alone, whose risk is lower, or women treated elsewhere. These boundaries keep the project to what one candidate can do with one site's records and a limited number of interviews.

The Candidate's Position

Managing the lymphedema clinic gives the candidate an advantage and a liability at once. She knows the pathway and the staff, and she has access to the clinic's records. She is also a stakeholder whose clinic's referrals are part of what will be studied, and staff and patients may answer her differently than they would a stranger. A plan to manage that position will be developed with the committee.

Feasibility at a Glance

The center performs about [95] axillary dissections a year, so two years of records would include close to two hundred women, enough to describe each step of the pathway with reasonable precision. The candidate has protected time for project work two days a month and access to a research mentor in the breast program. The main uncertainty is whether the record captures each step in a field that can be extracted, rather than in free-text notes, which a later feasibility appraisal will check. A second uncertainty is whether women who left the pathway will agree to be interviewed by someone from the clinic they did not attend.

Tentative Design

An explanatory sequential mixed methods design is likely: first, a records review to locate where women leave the pathway; then, interviews to explain why (Ivankova et al., 2006). The design will be settled in later units, once the question is final.

Next Steps

The candidate will draft a problem statement, confirm with the breast program director that aggregate figures may be cited in the proposal and begin a preliminary literature map.

References

DiSipio, T., Rye, S., Newman, B., & Hayes, S. (2013). Incidence of unilateral arm lymphoedema after breast cancer: A systematic review and meta-analysis. The Lancet Oncology, 14(6), 500-515. https://doi.org/10.1016/S1470-2045(13)70076-7

Ivankova, N. V., Creswell, J. W., & Stick, S. L. (2006). Using mixed-methods sequential explanatory design: From theory to practice. Field Methods, 18(1), 3-20. https://doi.org/10.1177/1525822X05282260

Ridner, S. H., Dietrich, M. S., Cowher, M. S., Taback, B., McLaughlin, S., Ajkay, N., Boyages, J., Koelmeyer, L., DeSnyder, S. M., Wagner, J., Abramson, V., Moore, A., & Shah, C. (2019). A randomized trial evaluating bioimpedance spectroscopy versus tape measurement for the prevention of lymphedema following treatment for breast cancer: Interim analysis. Annals of Surgical Oncology, 26(10), 3250-3259. https://doi.org/10.1245/s10434-019-07344-5

Stout Gergich, N. L., Pfalzer, L. A., McGarvey, C., Springer, B., Gerber, L. H., & Soballe, P. (2008). Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer, 112(12), 2809-2819. https://doi.org/10.1002/cncr.23494

Stout, N. L., Binkley, J. M., Schmitz, K. H., Andrews, K., Hayes, S. C., Campbell, K. L., McNeely, M. L., Soballe, P. W., Berger, A. M., Cheville, A. L., Fabian, C., Gerber, L. H., Harris, S. R., Johansson, K., Pusic, A. L., Prosnitz, R. G., & Smith, R. A. (2012). A prospective surveillance model for rehabilitation for women with breast cancer. Cancer, 118(S8), 2191-2200. https://doi.org/10.1002/cncr.27476